Skip to main content
SpringerLink
Log in
Book cover

The Diabetic Kidney pp 527–548Cite as

Anemia and Diabetic Nephropathy

  • Chapter

  • 1333 Accesses

Part of the book series: Contemporary Diabetes ((CDI))

Abstract

Although anemia is a common problem in patients with chronic kidney disease (CKD), it is only in the last decade that an appreciation of its potential impact in patients with diabetes has emerged (1,2). The prevalence of anemia in patients with diabetes is twice that seen in patients with nondiabetic renal disease and similar renal function. Approximately one in five patients with type 1 or 2 diabetes have hemoglobin (Hb) levels below the gender-specific normal range. Importantly, it is patients with vascular complications that are both at increased risk for anemia, and are most likely to suffer its adverse consequences.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Inomata S, Itoh M, Imai H, Sato T. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997;75:426–430.

    Article  PubMed  CAS  Google Scholar 

  2. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001;24:495–499.

    Article  PubMed  CAS  Google Scholar 

  3. Silverberg D. Outcomes of anemia management in renal insufficiency and cardiac disease. Nephrol Dial Transplant 2003;18(2):ii7–i1 2.

    PubMed  Google Scholar 

  4. Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1989;74:645–651.

    PubMed  CAS  Google Scholar 

  5. Lacombe C, Da Silva JL, Bruneval P, et al. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 1988;81:620–623.

    PubMed  CAS  Google Scholar 

  6. Maxwell PH, Osmond MK, Pugh CW, et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993;44:1149–1162.

    Article  PubMed  CAS  Google Scholar 

  7. Maxwell PH, Pugh CW, Ratcliffe PJ. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA 1993;90:2423–2427.

    Article  PubMed  CAS  Google Scholar 

  8. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993;90:4304–4308.

    Article  PubMed  CAS  Google Scholar 

  9. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996;271:17,771–17,778.

    Article  PubMed  CAS  Google Scholar 

  10. Semenza GL, Agani F, Booth G, et al. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 1997;51:553–555.

    Article  PubMed  CAS  Google Scholar 

  11. Eckardt KU. Biology of erythropoietin production. Nephrol Dial Transplant 1995;10:1572–1574.

    PubMed  CAS  Google Scholar 

  12. Thomas MC, Cooper ME, Tsalamandris C, MacIsaac R, Jerums G. Anemia with impaired erythropoietin response in diabetic patients. Arch Intern Med 2005;165:466–469.

    Article  PubMed  Google Scholar 

  13. Thomas M, Burns W, Cooper M. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 2005;12:177–186.

    Article  PubMed  CAS  Google Scholar 

  14. Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 2000;75:S22–S226.

    Article  PubMed  CAS  Google Scholar 

  15. Oldfield MD, Bach LA, Forbes JM, et al. Advanced glycation end products cause epithelialmyofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001;108:1853–1863.

    Article  PubMed  CAS  Google Scholar 

  16. Yoshida H, Kuriyama S, Atsumi Y, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996;50:657–664.

    Article  PubMed  CAS  Google Scholar 

  17. Bosman DR, Osborne CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ. Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med 2002;19:65–69.

    Article  PubMed  CAS  Google Scholar 

  18. Baba T, Nakajima S, Yajima Y. Beta3-adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy. Horm Metab Res 1998;30:629–632.

    PubMed  CAS  Google Scholar 

  19. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective communitybased atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 2003;14:2919–2925.

    Article  PubMed  CAS  Google Scholar 

  20. Thomas MC, Tsalamandris C, MacIsaac R, Jerums G. Anemia in diabetes: An emerging complication of microvascuar disease. Current Diabetes Reviews 2005;1:107–126.

    Article  CAS  PubMed  Google Scholar 

  21. Craig KJ, Williams JD, Riley SG, et al. Anemia and diabetes in the absence of nephropathy. Diabetes Care 2005;28:1118–1123.

    Article  PubMed  Google Scholar 

  22. Deicher R, Horl WH. Anemia as a risk factor for the progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2003;12:139–143.

    Article  PubMed  CAS  Google Scholar 

  23. Keane WF, Lyle PA. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. Am J Kidney Dis 2003;41:S22–S25.

    Article  PubMed  CAS  Google Scholar 

  24. Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis 2001;38:1398–1407.

    PubMed  CAS  Google Scholar 

  25. Guest CS, Ratnaike S, Larkins RG. Albuminuria in aborigines and Europids of south-eastern Australia. Med J Aust 1993;159:335–338.

    PubMed  CAS  Google Scholar 

  26. Sinclair SH. Diabetic macular edema: New concepts of pathology and treatment. Semin Ophthalmol 1999;14:197–199.

    PubMed  Google Scholar 

  27. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10,457–10,461.

    Article  PubMed  CAS  Google Scholar 

  28. Friedman EA, L’Esperance FA, Brown CD, Berman DH. Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. Kidney Int Suppl 2003:S57–S63.

    Google Scholar 

  29. Berman DH, Friedman EA. Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin. Retina 1994;14:1–5.

    PubMed  CAS  Google Scholar 

  30. Friedman EA, Brown CD, Berman DH. Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 1995;26:202–208.

    PubMed  CAS  Google Scholar 

  31. Bianchi R, Buyukakilli B, Brines M, et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA 2004;101:823–828.

    Article  PubMed  CAS  Google Scholar 

  32. Hassan K, Simri W, Rubenchik I, et al. Effect of erythropoietin therapy on polyneuropathy in predialytic patients. J Nephrol 2003;16:121–125.

    PubMed  CAS  Google Scholar 

  33. Ribatti D, Presta M, Vacca A, et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999;93:2627–2636.

    PubMed  CAS  Google Scholar 

  34. Carlini RG, Alonzo EJ, Dominguez J, et al. Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int 1999;55:546–553.

    Article  PubMed  CAS  Google Scholar 

  35. Akimoto T, Kusano E, Inaba T, et al. Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway. Kidney Int 2000;58:269–282.

    Article  PubMed  CAS  Google Scholar 

  36. Cotroneo P, Maria Ricerca B, Todaro L, et al. Blunted erythropoietin response to anemia in patients with Type 1 diabetes. Diabetes Metab Res Rev 2000;16:172–176.

    Article  PubMed  CAS  Google Scholar 

  37. Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002;13:504–510.

    Article  PubMed  CAS  Google Scholar 

  38. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 2002;162:1401–1408.

    Article  PubMed  Google Scholar 

  39. El-Achkar TM, Ohmit SE, McCullough PA, et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney Int 2005;67:1483–1488.

    Article  PubMed  Google Scholar 

  40. Valderrabano F. Anemia management in chronic kidney disease patients: an overview of current clinical practice. Nephrol Dial Transplant 2002;17(1):13–18.

    Article  PubMed  Google Scholar 

  41. Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care 2003;26:1164–1169.

    Article  PubMed  Google Scholar 

  42. Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G. Elevated iron indices in patients with diabetes. Diabet Med 2004;21:798–802.

    Article  PubMed  CAS  Google Scholar 

  43. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002;51:2348–2354.

    Article  PubMed  CAS  Google Scholar 

  44. Thomas MC, MacIsaac RJ, Tsalamandris C, et al. The burden of anemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit. Nephrol Dial Transplant 2004;19:1792–1797.

    Article  PubMed  Google Scholar 

  45. Thomas MC, MacIsaac RJ, Tsalamandris C, et al. Anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2004;89:4359–4363.

    Article  PubMed  CAS  Google Scholar 

  46. Thomas MC, Tsalamandris C, MacIsaac R, et al. Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int 2004;66:1167–1172.

    Article  PubMed  CAS  Google Scholar 

  47. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5–10.

    Article  PubMed  CAS  Google Scholar 

  48. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154–2169.

    Article  PubMed  Google Scholar 

  49. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279:217–221.

    Article  PubMed  CAS  Google Scholar 

  50. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis 1996;28:53–61.

    PubMed  CAS  Google Scholar 

  51. Mann JF What are the short-term and long-term consequences of anemia in CRF patients? Nephrol Dial Transplant 1999;14(2):29–36.

    Article  PubMed  Google Scholar 

  52. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780–1786.

    Article  PubMed  Google Scholar 

  53. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003;107:223–225.

    Article  PubMed  Google Scholar 

  54. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999;34:125–134.

    PubMed  CAS  Google Scholar 

  55. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114:112–119.

    Article  PubMed  Google Scholar 

  56. Madore F, Lowrie EG, Brugnara C, et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 1997;8:1921–1929.

    PubMed  CAS  Google Scholar 

  57. Collins AJ, Li S, St Peter W, et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 2001;12:2465–2473.

    PubMed  CAS  Google Scholar 

  58. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 2003;64:610–615.

    Article  PubMed  Google Scholar 

  59. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 2003;63:1908–1914.

    Article  PubMed  Google Scholar 

  60. Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol 2003;60(1):S93–S102.

    PubMed  Google Scholar 

  61. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584–590.

    Article  PubMed  CAS  Google Scholar 

  62. London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001;12:2759–2767.

    PubMed  CAS  Google Scholar 

  63. Furuland H, Linde T, Ahlmen J, Christensson A, Strombom U, Danielson BG. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant 2003;18:353–361.

    Article  PubMed  CAS  Google Scholar 

  64. Silverberg DS, Wexler D, Blum M, et al. The effect of correction of anemia in diabetics and nondiabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003;18:141–146.

    Article  PubMed  CAS  Google Scholar 

  65. Strippoli GF, Craig JC, Manno C, Schena FP Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2004;15:3154–3165.

    Article  PubMed  Google Scholar 

  66. Macdougall IC. CREATE: new strategies for early anemia management in renal insufficiency. Nephrol Dial Transplant 2003;18(2):ii13–ii16.

    PubMed  Google Scholar 

  67. Reddan D, Tran L-L, Jollis L, Singh A. Anemia correction and left ventricular hypertrophy: an echocardiographic substudy of the Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) study. J Am Soc Nephrol 2002;13:676A.

    Google Scholar 

  68. Laville M. New strategies in anemia management: ACORD (Anemia Correction in Diabetes) trial. Acta Diabetol 2004;41(1):S18–S22.

    Article  PubMed  Google Scholar 

  69. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ. Erythropoietin depletion and anemia in diabetes mellitus. Diabet Med 1999;16:813–819.

    Article  PubMed  CAS  Google Scholar 

  70. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955–962.

    Article  PubMed  CAS  Google Scholar 

  71. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928–1936.

    Article  PubMed  Google Scholar 

  72. Collins AJ. The hemoglobin link to adverse outcomes. Adv Studies in Med 2003;3:S14–S17.

    Google Scholar 

  73. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 1997;77:176–185.

    Article  PubMed  CAS  Google Scholar 

  74. Roger SD, McMahon LP, Clarkson A, et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. J Am Soc Nephrol 2004;15:148–156.

    Article  PubMed  CAS  Google Scholar 

  75. Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004;66:753–760.

    Article  PubMed  Google Scholar 

  76. Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226–229.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baker Medical Research Institute, Melbourne, Australia

    Merlin Thomas MB, CHB, PhD

  2. Endocrine Unit and Department of Medicine, University of Melbourne, Melbourne, Australia

    George Jerums MBBS, MD, FRACP, Richard MacIsaac PhD, MD, FRACP & Sianna Panagiotopoulos PhD

Authors
  1. George Jerums MBBS, MD, FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard MacIsaac PhD, MD, FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sianna Panagiotopoulos PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Merlin Thomas MB, CHB, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Nephrology and Hypertension, Department of Medicine, Henry Ford Hospital, Detroit, MI

    Pedro Cortes MD

  2. Department of Internal Medicine M (Diabetes and Endocrinology), Aarhus University Hospital, Aarhus, Denmark

    Carl Erik Mogensen MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Jerums, G., MacIsaac, R., Panagiotopoulos, S., Thomas, M. (2006). Anemia and Diabetic Nephropathy. In: Cortes, P., Mogensen, C.E. (eds) The Diabetic Kidney. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-59745-153-6_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-153-6_30

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-624-5

  • Online ISBN: 978-1-59745-153-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation